Loading...
Both aspirin and warfarin are effective methods of secondary prevention after myocardial infarction, but their role in primary prevention of ischemic heart disease (IHD) remains unsettled. In this trial from the U.K., 5,085 men aged 45 to 69 and at high risk for IHD were randomized to low-dose aspirin (75 mg daily), low-dose warfarin (enough to keep the INR around 1.5; mean dose, 4 mg), aspirin and warfarin combined, or placebo. Patients in the top 20 to 25 percent of risk for IHD based on initial measurements of smoking, blood pressure, body mass index, cholesterol, and clotting factors were included in the trial. Patients with a history of peptic ulcer, myocardial infarction, or stroke were excluded.
There were 410 IHD events, one third of…